Total neoadjuvant therapy with FOLFIRINOX followed by individualized chemoradiotherapy for borderline resectable pancreatic adenocarcinoma: a phase 2 clinical trial - Murphy, J E; Wo, J Y; Ryan, D P (JAMA Oncol, 2018)
et al.